62 related articles for article (PubMed ID: 9576017)
1. [Toxicity and radiation dosage of 2-(18F)-2-desoxy-D-glucose in positron emission tomography].
Ruhlmann J; Oehr P; Bender H; Kozak B; Willkomm P; Bechtold V; Lind P; Biersack HJ
Acta Med Austriaca; 1998; 25(1):1-6. PubMed ID: 9576017
[TBL] [Abstract][Full Text] [Related]
2. Technologist radiation exposure in routine clinical practice with 18F-FDG PET.
Guillet B; Quentin P; Waultier S; Bourrelly M; Pisano P; Mundler O
J Nucl Med Technol; 2005 Sep; 33(3):175-9. PubMed ID: 16145226
[TBL] [Abstract][Full Text] [Related]
3. Estimated radiation dose to the newborn in FDG-PET studies.
Ruotsalainen U; Suhonen-Polvi H; Eronen E; Kinnala A; Bergman J; Haaparanta M; Teräs M; Solin O; Wegelius U
J Nucl Med; 1996 Feb; 37(2):387-93. PubMed ID: 8667081
[TBL] [Abstract][Full Text] [Related]
4. Radiation dose to the bladder wall from 2-[18F]fluoro-2-deoxy-D-glucose in adult humans.
Dowd MT; Chen CT; Wendel MJ; Faulhaber PJ; Cooper MD
J Nucl Med; 1991 Apr; 32(4):707-12. PubMed ID: 2013811
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
Jackson RS; Schlarman TC; Hubble WL; Osman MM
J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
[TBL] [Abstract][Full Text] [Related]
6. Operational radiation safety for PET-CT, SPECT-CT, and cyclotron facilities.
Zanzonico P; Dauer L; St Germain J
Health Phys; 2008 Nov; 95(5):554-70. PubMed ID: 18849690
[TBL] [Abstract][Full Text] [Related]
7. [Inhibition of 18F-FDG uptake in glioblastoma cells by FDG and glucose].
Oehr P; Ruhlmann J; Kozak B; Brock H; Thieme D; Rink H
Acta Med Austriaca; 1999; 26(3):101-3. PubMed ID: 10520378
[TBL] [Abstract][Full Text] [Related]
8. Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
Mullani NA; Herbst RS; O'Neil RG; Gould KL; Barron BJ; Abbruzzese JL
J Nucl Med; 2008 Apr; 49(4):517-23. PubMed ID: 18344436
[TBL] [Abstract][Full Text] [Related]
9. Estimation of the beta+ dose to the embryo resulting from 18F-FDG administration during early pregnancy.
Zanotti-Fregonara P; Champion C; Trébossen R; Maroy R; Devaux JY; Hindié E
J Nucl Med; 2008 Apr; 49(4):679-82. PubMed ID: 18344434
[TBL] [Abstract][Full Text] [Related]
10. Whole-body radiation dosimetry of 2-[18F]Fluoro-A-85380 in human PET imaging studies.
Obrzut SL; Koren AO; Mandelkern MA; Brody AL; Hoh CK; London ED
Nucl Med Biol; 2005 Nov; 32(8):869-74. PubMed ID: 16253812
[TBL] [Abstract][Full Text] [Related]
11. Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations.
Brix G; Lechel U; Glatting G; Ziegler SI; Münzing W; Müller SP; Beyer T
J Nucl Med; 2005 Apr; 46(4):608-13. PubMed ID: 15809483
[TBL] [Abstract][Full Text] [Related]
12. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction.
Kang WJ; Kang HJ; Kim HS; Chung JK; Lee MC; Lee DS
J Nucl Med; 2006 Aug; 47(8):1295-301. PubMed ID: 16883008
[TBL] [Abstract][Full Text] [Related]
13. Doses to nuclear technicians in a dedicated PET/CT centre utilising 18F fluorodeoxyglucose (FDG).
Seierstad T; Stranden E; Bjering K; Evensen M; Holt A; Michalsen HM; Wetteland O
Radiat Prot Dosimetry; 2007; 123(2):246-9. PubMed ID: 16987913
[TBL] [Abstract][Full Text] [Related]
14. Radiation protection for accompanying person and radiation workers in PET/CT.
Demir M; Demir B; Sayman H; Sager S; Sabbir Ahmed A; Uslu I
Radiat Prot Dosimetry; 2011 Nov; 147(4):528-32. PubMed ID: 21183551
[TBL] [Abstract][Full Text] [Related]
15. Radiation exposure to sonographers from fluorine-18-FDG PET patients.
Griff M; Berthold T; Buck A
J Nucl Med Technol; 2000 Sep; 28(3):186-7. PubMed ID: 11001504
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
17. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
18. Radiation dose to PET technologists and strategies to lower occupational exposure.
Roberts FO; Gunawardana DH; Pathmaraj K; Wallace A; U PL; Mi T; Berlangieri SU; O'Keefe GJ; Rowe CC; Scott AM
J Nucl Med Technol; 2005 Mar; 33(1):44-7. PubMed ID: 15731021
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced DNA damage and the relative biological effectiveness of 18F-FDG in wild-type mice.
Taylor K; Lemon JA; Boreham DR
Mutagenesis; 2014 Jul; 29(4):279-87. PubMed ID: 24870562
[TBL] [Abstract][Full Text] [Related]
20. Radiation dose to positron emission tomography technologists during quantitative versus qualitative studies.
McCormick VA; Miklos JA
J Nucl Med; 1993 May; 34(5):769-72. PubMed ID: 8478709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
